Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753216
Status:
COMPLETED
Last Update Posted:
2023-01-19
First Post:
2021-02-10
Brief Title:
Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant Recurrent or Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer
Sponsor:
Northwestern University
Organization:
Northwestern University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Primary Peritoneal Carcinoma |
| Platinum-Resistant Fallopian Tube Carcinoma |
| Platinum-Resistant Ovarian Carcinoma |
| Platinum-Resistant Primary Peritoneal Carcinoma |
| Recurrent Fallopian Tube Carcinoma |
| Recurrent Ovarian Carcinoma |
| Recurrent Primary Peritoneal Carcinoma |
| Refractory Fallopian Tube Carcinoma |
| Refractory Ovarian Carcinoma |
Keywords: